Where to buy Cemiplimab

Cemiplimab (Cemiplimab) is mainly used to treat advanced squamous cell carcinoma (SCC) and non-small cell lung cancer with high PD-L1 (programmed death ligand-1) expression. Cimepilimab is unique in its mechanism of action. It is an immune checkpoint inhibitor designed to enhance the immune system's attack on cancer cells. Cimepilimab is not currently available in China, so patients cannot purchase it domestically and need to purchase cimepilimab through overseas channels. There are only cimipri monoclonal origin drugs abroad, mainly European and American versions. For specific prices and information about overseas drugs, please consult a medical consultant.